Medtronic Completes Separation of MiniMed

Medtronic Acquires SPR Therapeutics

May 20, 2026

Healthcare Services

Medtronic agreed to acquire SPR Therapeutics for approximately $650 million in cash to add SPR’s FDA-cleared Sprint (SPRINT) temporary peripheral nerve stimulation (PNS) technology to its neuromodulation/pain portfolio. Medtronic later completed the acquisition, integrating the SPRINT PNS System to expand minimally invasive, non-opioid chronic and acute pain treatment options.

CorMedix Acquires Melinta Therapeutics for $300 Million

August 7, 2025

Biotechnology

CorMedix Inc. has entered into a definitive agreement to acquire Melinta Therapeutics, paying $300 million upfront (including $260 million cash and $40 million in CorMedix equity to Melinta shareholders), plus up to $25 million in a regulatory milestone and tiered royalties. The deal is expected to close in September, subject to customary closing conditions and U.S. regulatory approval.

Mallinckrodt Completes Merger with Endo to Form Global Therapeutics Leader

August 1, 2025

Pharmaceuticals

Mallinckrodt plc and Endo, Inc. completed their merger to create a global, scaled, diversified therapeutics leader. The transaction combines Mallinckrodt’s branded portfolio with Endo’s generics and sterile injectables business (Par Health), which is intended to be spun off as a standalone independent company targeted for the fourth quarter of 2025.

Medtronic Acquires Nano Surface Technology Assets from Nanovis

February 12, 2025

Medical Devices

Medtronic plc acquired certain nano surface technology assets and related IP rights from Columbia City, Indiana-based Nanovis to support development of next-generation PEEK interbody fusion devices. Financial terms were not disclosed; the deal transfers Nanovis’ bone-growth nanotechnology (including rights related to Sites Medical’s OsteoSync titanium pads) to Medtronic for integration into its spinal implant portfolio.

ExcelFin Acquisition Corp Completes Business Combination With Baird Medical Investment Holdings Limited

October 1, 2024

Medical Devices

ExcelFin Acquisition Corp and Baird Medical Investment Holdings Limited completed their previously announced business combination, creating a Nasdaq-listed public company, PubCo (ticker: BDMD). Following the closing, founders of Baird Medical and Grand Fortune Capital (co-sponsor of ExcelFin) subscribed to a $4.9 million convertible preferred investment.

MTD Group Acquires Ypsomed's Pen Needles and Blood Glucose Monitoring Businesses

August 2, 2024

Medical Devices

MTD Group (Medical Technology and Devices) has completed the acquisition of Ypsomed’s pen needles and blood glucose monitoring systems businesses. The deal expands MTD’s diabetes and obesity care portfolio, increases European production capacity to over 2.5 billion pen needles, and provides entry into high-growth markets including China and India while prompting a significant investment plan for European production sites.